Medacta Group SA is a healthcare company based in Switzerland with a medium risk rating score of 28.2 on ESG factors. Specializing in orthopedic and neurosurgical medical devices, Medacta Group SA provides solutions for Hip, Knee, Shoulder, and Spine. The company primarily generates revenue from Europe, the Middle East, and Africa (EMEA) as well as other regions.